D-0038-2027 Class II Ongoing
FDA drug recall D-0038-2027 was initiated by Teva Pharmaceuticals USA, Inc on Sep 29, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: 240,448 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 21, 2026
- Initiation Date
- Sep 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 240,448 cartons
Product Description
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
Reason for Recall
Presence of Foreign Tablets/Capsules
Distribution Pattern
US Nationwide.
Code Information
Lot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0038-2027
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026